NCT06814977 An Acupuncture Study for Cancer Survivors With Joint Pain
| NCT ID | NCT06814977 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Cancer Survivor |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-01-31 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-01-31 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.
Eligibility Criteria
Inclusion Criteria: * English- or Spanish-speaking adults * Non white or Hispanic women with a prior cancer diagnosis * Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment * Worst pain rated ≥4 on a 0-10 scale in the preceding week * ≥15 days with pain in the past 30 days * Pain lasting ≥1 month * Willing and able to complete questionnaires and other study activities * Willing and able to provide informed consent for the trial Exclusion Criteria: * Completed active treatment (chemotherapy, surgery, radiation, transplantation) \<4 weeks prior to study * Maintenance therapies are allowed * Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout) * Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain * Procedures involving affected joints within the last month or planned in the next 14 weeks * Acupuncture use for pain in the past three months * Implanted electronic device (e.g., pacemaker)
Contact & Investigator
Kevin Liou, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT06814977 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Survivor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06814977 currently recruiting?
Yes, NCT06814977 is actively recruiting participants. Contact the research team at liouk@mskcc.org for enrollment information.
Where is the NCT06814977 trial being conducted?
This trial is being conducted at New York, United States, Richmond Hill, United States.
Who is sponsoring the NCT06814977 clinical trial?
NCT06814977 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Kevin Liou, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.